The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel

被引:13
作者
Chodick, Gabriel [1 ,2 ]
Green, Manfred S. [2 ,3 ]
Heymann, Anthony D. [1 ]
Rosenmann, Lena [1 ,2 ]
Shalev, Varda [1 ]
机构
[1] Maccabi Healthcare Serv, Dept Med Informat, IL-68125 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Sheba Med Ctr, Gertner Inst, Israel Ctr Dis Control, Minist Hlth, Ramat Gan, Israel
关键词
hepatitis A; immunization; epidemiology;
D O I
10.1016/j.ypmed.2007.05.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. In 1999 Israel became the first country to introduce immunization against hepatitis A to its national childhood vaccination program. The study objectives were to assess the uptake of hepatitis A vaccine following the new policy and to examine the incidence of hepatitis A and the number of prevented cases. Methods. Data on incidence of hepatitis A and vaccination rates were obtained from a large health maintenance organization in Israel covering 1.6 million members. We identified all members that were diagnosed by a primary care physician as suffering from hepatitis A, had a positive hepatitis A virus-IgM test result, or were hospitalized due to hepatitis A between 1998 and 2004. Results. The results indicate that 5 years following its inclusion in the national childhood immunization program, vaccination coverage levels with at least one dose of hepatitis A vaccine for children aged under 5 years and 5-14 years were 87% and 51%, respectively. During this period the annual incidence rates declined by 88% from 142.4 to 17.3 per 100,000. The most significant reduction in morbidity was observed among children. Conclusions. In endemic areas, vaccination of infants and children against hepatitis A may be efficient to greatly reduce the total burden of the disease. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:386 / 391
页数:6
相关论文
共 35 条
[1]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[2]   Control of hepatitis A through routine vaccination of children [J].
Averhoff, F ;
Shapiro, CN ;
Bell, BP ;
Hyams, I ;
Burd, L ;
Deladisma, A ;
Simard, EP ;
Nalin, D ;
Kuter, B ;
Ward, C ;
Lundberg, M ;
Smith, N ;
Margolis, HS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23) :2968-2973
[3]   Hepatitis a incidence and hepatitis a vaccination among American Indians and Alaska natives, 1990-2001 [J].
Bialek, SR ;
Thoroughman, DA ;
Hu, D ;
Simard, EP ;
Chattin, J ;
Cheek, J ;
Bell, BP .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (06) :996-1001
[4]   Detection of immunoglobulin m antibody to hepatitis A virus in Alaska residents without other evidence of hepatitis [J].
Castrodale, L ;
Fiore, A ;
Schmidt, T .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :E86-E88
[5]  
*CDC, 1987, 51 HEP SURV
[6]   The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies [J].
Chodick, G ;
Ashkenazi, S ;
Lerman, Y .
JOURNAL OF HOSPITAL INFECTION, 2006, 62 (04) :414-420
[7]   Cost-utility analysis of hepatitis A prevention among health-care workers in Israel [J].
Chodick, G ;
Lerman, Y ;
Wood, F ;
Aloni, H ;
Peled, T ;
Ashkenazi, S .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 44 (02) :109-115
[8]   Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel [J].
Chodick, G ;
Lerman, Y ;
Peled, T ;
Aloni, H ;
Ashkenazi, S .
PHARMACOECONOMICS, 2001, 19 (03) :281-291
[9]   Incidence of hepatitis A in Israel following universal immunization of toddlers [J].
Dagan, R ;
Leventhal, A ;
Anis, E ;
Slater, P ;
Ashur, Y ;
Shouval, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02) :202-210
[10]   Hepatitis A antibody prevalence among young adults in Israel - the decline continues [J].
Gdalevich, M ;
Grotto, I ;
Mandel, Y ;
Mimouni, D ;
Shemer, J ;
Ashkenazi, I .
EPIDEMIOLOGY AND INFECTION, 1998, 121 (02) :477-479